Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06331767 |
Other study ID # |
2024P000654 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 2024 |
Est. completion date |
April 2029 |
Study information
Verified date |
March 2024 |
Source |
Brigham and Women's Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The goal of this clinical trial is to pilot test a psychosocial-behavioral mobile health
(mHealth) human immunodeficiency virus (HIV) prevention intervention in people who use drugs
presenting to the emergency department (ED). The main question the study aims to answer is:
is the intervention acceptable and appropriate? Participants will use the mHealth app while
waiting in the ED and also at home for 90 days. Participants will be asked to complete
surveys at baseline, before leaving the ED, and at 30-, 60-, and 90-day follow up visits.
Description:
"mSYNC" (mHealth SYNdemic-based Consultation & liaison) is an mHealth HIV prevention
intervention to be initially delivered at point-of-care during a visit to the emergency
department with continued on demand access to intervention app at home. mSYNC simulates
hospital-based consultation and liaison psychology service by intervening on the interrelated
health risk behaviors, mental health issues, and structural/treatment needs (e.g., housing,
drug use treatment). Capitalizing on the syndemic domino effect, mSYNC aims to promote
prevention via entry into at least one of three interacting pathways: decreased HIV/drug use
risk behaviors, decreased severity of mental health symptoms, and increased linkage to
services. A pilot single-arm feasibility test will be conducted to assess patient-level
implementation outcomes of acceptability and appropriateness of the mHealth intervention.
Secondarily, change over time will be explored for HIV risk, drug use, mental health
symptoms, and linkage to care. The study will take place in two urban emergency departments
in Boston, Massachusetts. A sample of N=100 people who use drugs (PWUD) who also belong to
other key HIV risk groups (transgender women, men who have sex with men [MSM],
Black/Latinx/Indigenous people) will be enrolled during a visit to the emergency department.
Research staff will pre-screen individuals checked-in and waiting in the emergency department
for potential eligibility via information from electronic medical chart (HIV risk or drug use
indicator). Staff will then approach potentially eligible patients identified from this
pre-screen to describe the study and invite them to be screened for eligibility. Once
screened eligible, participants will complete a baseline survey and asked to engage with the
mHealth intervention app during their time in the ED (environment- and person-driven
intervention dosage). Before discharge, participants will complete a brief feedback survey
and asked to use to mHealth at home for at least one time a week for the next 90 days
(environment- and person-driven intervention dosage) with the help of automatic notifications
personalized to the person. Participants will complete a remote follow-up at 30, 60, and 90
days consisting of a quantitative survey and exit interview (90-day follow-up only).